Literature DB >> 9001425

Mutation analysis of the WT1 gene in sporadic childhood leukaemia.

E Algar1, D Blackburn, T Kromykh, G Taylor, P Smith.   

Abstract

The 10 coding exons of the WT1 gene, from 39 bp upstream of the translation initiation codon to 12 bp downstream of the stop codon, were examined for point mutations in a panel of 48 sporadic childhood acute leukaemias using the single-stranded conformational polymorphism (SSCP) assay. The panel included 33 cases of acute lymphocytic leukaemia and 15 cases of acute myeloid leukaemia. This is the first study in which sporadic childhood leukaemias have been examined for WT1 point mutations across the entire coding region of the WT1 gene, however, no tumorigenic point mutations or small deletions or insertions could be identified in these patients. A previously described polymorphism in exon 7, resulting in an A to G transition in an arginine codon, was observed at a frequency of 21.5%, equivalent to that seen in the normal population. This study suggests that point mutations in the coding regions of the WT1 occur infrequently in leukaemias of childhood.

Entities:  

Mesh:

Year:  1997        PMID: 9001425     DOI: 10.1038/sj.leu.2400521

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  5 in total

Review 1.  The possible role and application of WT1 in human leukemia.

Authors:  Z Chen
Journal:  Int J Hematol       Date:  2001-01       Impact factor: 2.490

Review 2.  Wilms' tumor gene WT1: its oncogenic function and clinical application.

Authors:  H Sugiyama
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

3.  Par4 is a coactivator for a splice isoform-specific transcriptional activation domain in WT1.

Authors:  D J Richard; V Schumacher; B Royer-Pokora; S G Roberts
Journal:  Genes Dev       Date:  2001-02-01       Impact factor: 11.361

4.  WT1 intron 9 splice acceptor site mutation in a 46,XY male with focal segmental glomerulosclerosis.

Authors:  Katsuyoshi Kanemoto; Kenji Ishikura; Daisuke Ariyasu; Yuko Hamasaki; Hiroshi Hataya; Yukihiro Hasegawa; Masahiro Ikeda
Journal:  Pediatr Nephrol       Date:  2006-10-24       Impact factor: 3.714

5.  CDKN1C expression in Beckwith-Wiedemann syndrome patients with allele imbalance.

Authors:  E M Algar; G J Deeble; P J Smith
Journal:  J Med Genet       Date:  1999-07       Impact factor: 6.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.